Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8183446rdf:typepubmed:Citationlld:pubmed
pubmed-article:8183446lifeskim:mentionsumls-concept:C0032019lld:lifeskim
pubmed-article:8183446lifeskim:mentionsumls-concept:C0333275lld:lifeskim
pubmed-article:8183446pubmed:issue2lld:pubmed
pubmed-article:8183446pubmed:dateCreated1994-6-16lld:pubmed
pubmed-article:8183446pubmed:abstractTextIn a group of 69 patients with pituitary tumours, 12 were found to have evidence of intratumoral haemorrhage on MRI, characterized by high signal intensity on short TR/TE sequences. This was verified in all but 1 patient. The majority of the bleedings occurred in macroadenomas. Five (42%) were prolactinomas and 4 (33%) were non-functioning adenomas. There were 2 GH- and 1 ACTH-secreting tumours. All 5 patients with prolactinomas were on bromocriptine medication. Two of the patients had a clinical picture of pituitary apoplexy. The haemorrhage was not large enough to prompt surgery in any of the patients. However, surgical verification of the diagnosis was obtained in 5 cases, while 6 patients were examined with follow-up MRI.lld:pubmed
pubmed-article:8183446pubmed:languageenglld:pubmed
pubmed-article:8183446pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8183446pubmed:citationSubsetIMlld:pubmed
pubmed-article:8183446pubmed:statusMEDLINElld:pubmed
pubmed-article:8183446pubmed:issn0028-3940lld:pubmed
pubmed-article:8183446pubmed:authorpubmed-author:EricsonKKlld:pubmed
pubmed-article:8183446pubmed:authorpubmed-author:WersällJJlld:pubmed
pubmed-article:8183446pubmed:authorpubmed-author:HindmarshTTlld:pubmed
pubmed-article:8183446pubmed:authorpubmed-author:SamiMMlld:pubmed
pubmed-article:8183446pubmed:authorpubmed-author:HultingA LALlld:pubmed
pubmed-article:8183446pubmed:authorpubmed-author:FryV FVFlld:pubmed
pubmed-article:8183446pubmed:authorpubmed-author:LazaroC MCMlld:pubmed
pubmed-article:8183446pubmed:issnTypePrintlld:pubmed
pubmed-article:8183446pubmed:volume36lld:pubmed
pubmed-article:8183446pubmed:ownerNLMlld:pubmed
pubmed-article:8183446pubmed:authorsCompleteYlld:pubmed
pubmed-article:8183446pubmed:pagination111-4lld:pubmed
pubmed-article:8183446pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:8183446pubmed:meshHeadingpubmed-meshheading:8183446-...lld:pubmed
pubmed-article:8183446pubmed:meshHeadingpubmed-meshheading:8183446-...lld:pubmed
pubmed-article:8183446pubmed:meshHeadingpubmed-meshheading:8183446-...lld:pubmed
pubmed-article:8183446pubmed:meshHeadingpubmed-meshheading:8183446-...lld:pubmed
pubmed-article:8183446pubmed:meshHeadingpubmed-meshheading:8183446-...lld:pubmed
pubmed-article:8183446pubmed:meshHeadingpubmed-meshheading:8183446-...lld:pubmed
pubmed-article:8183446pubmed:meshHeadingpubmed-meshheading:8183446-...lld:pubmed
pubmed-article:8183446pubmed:meshHeadingpubmed-meshheading:8183446-...lld:pubmed
pubmed-article:8183446pubmed:meshHeadingpubmed-meshheading:8183446-...lld:pubmed
pubmed-article:8183446pubmed:meshHeadingpubmed-meshheading:8183446-...lld:pubmed
pubmed-article:8183446pubmed:year1994lld:pubmed
pubmed-article:8183446pubmed:articleTitleHaemorrhagic pituitary tumours.lld:pubmed
pubmed-article:8183446pubmed:affiliationDepartment of Neuroradiology, Karolinska Sjukhuset, Stockholm, Sweden.lld:pubmed
pubmed-article:8183446pubmed:publicationTypeJournal Articlelld:pubmed